ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.
作者信息
Lv Minhao, Luo Suxia
机构信息
Department of Breast Disease, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
出版信息
Ann Surg Oncol. 2021 Sep;28(9):5110-5111. doi: 10.1245/s10434-020-09585-1. Epub 2021 Feb 2.
Abstract
摘要
相似文献
1
ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.ASO作者反思：同侧锁骨上淋巴结清扫术对乳腺癌的影响
Ann Surg Oncol. 2021 Sep;28(9):5110-5111. doi: 10.1245/s10434-020-09585-1. Epub 2021 Feb 2.
2
ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.《美国外科医师学会（ASO）作者反思：乳腺癌手术中前哨淋巴结阳性》
Ann Surg Oncol. 2022 Feb;29(2):1096-1097. doi: 10.1245/s10434-021-10836-y. Epub 2021 Sep 24.
3
ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?ASO作者反思：男性乳腺癌与腋窝淋巴结清扫术：是时候重新思考治疗方案了吗？
Ann Surg Oncol. 2023 Sep;30(9):5619-5620. doi: 10.1245/s10434-023-13627-9. Epub 2023 May 16.
4
ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.ASO作者反思：完善仅适合前哨淋巴结活检的淋巴结阳性乳腺癌患者的风险评估
Ann Surg Oncol. 2020 Oct;27(10):3593-3594. doi: 10.1245/s10434-020-08634-z. Epub 2020 May 21.
5
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?ASO作者反思：新辅助化疗后对淋巴结阳性乳腺癌进行前哨淋巴结手术：从肿瘤学角度看是否安全？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.
6
ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.ASO作者反思：基于微小RNA的列线图预测雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌前哨淋巴结转移，以期可能省略前哨淋巴结活检
Ann Surg Oncol. 2020 Dec;27(Suppl 3):810-811. doi: 10.1245/s10434-020-08797-9. Epub 2020 Jul 6.
7
ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.ASO作者反思：可避免完全腋窝清扫，但试验设计不一致使在替代策略间做出选择变得复杂。
Ann Surg Oncol. 2020 Aug;27(8):2677-2678. doi: 10.1245/s10434-020-08394-w. Epub 2020 Mar 23.
8
ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.ASO作者反思：临床淋巴结阴性患者新辅助化疗后前哨淋巴结切除在切除三个淋巴结后可停止。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):848-849. doi: 10.1245/s10434-020-08874-z. Epub 2020 Jul 21.
9
ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.ASO作者反思：新辅助化疗病理反应后仅接受前哨淋巴结活检的临床淋巴结阳性乳腺癌患者腋窝复发率低
Ann Surg Oncol. 2021 May;28(5):2630-2631. doi: 10.1245/s10434-020-09259-y. Epub 2020 Oct 29.
10
ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.ASO作者反思：前哨淋巴结活检对乳房切除术后胸壁复发的价值。
Ann Surg Oncol. 2022 Mar;29(3):1761-1762. doi: 10.1245/s10434-021-11042-6. Epub 2021 Nov 10.
本文引用的文献
1
Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).锁骨上淋巴结清扫术（ISLND）对乳腺癌患者的影响及预测同侧锁骨上病理完全缓解（ispCR）的列线图。
Ann Surg Oncol. 2021 Sep;28(9):5098-5109. doi: 10.1245/s10434-020-09548-6. Epub 2021 Feb 17.
2
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.原发性化疗后经细胞学证实的乳腺癌腋窝淋巴结转移灶病理完全清除后的结局
J Clin Oncol. 2005 Dec 20;23(36):9304-11. doi: 10.1200/JCO.2005.02.5023.
3
Revision of the American Joint Committee on Cancer staging system for breast cancer.美国癌症联合委员会乳腺癌分期系统的修订
J Clin Oncol. 2002 Sep 1;20(17):3628-36. doi: 10.1200/JCO.2002.02.026.
Zotero 插件